2. GENEL BİLGİLER
2.5. Çocuklarda Sağlıklı Yeme Davranışının Geliştirilmesinde Kullanılan
2.5.8. Hazırlama ve sunum farklılaştırma
pseudomallei, reduzindo sua biomassa e facilitando a penetração de antimicrobianos;
10 PERSPECTIVAS
O presente trabalho demonstrou resultados que vêm a somar conhecimentos a respeito da resistência apresentada por B. pseudomallei, acentuada pela formação de biofilme. Diante desta problemática, este trabalho trouxe perspectivas acerca do aumento da sensibilidade do biofilme de B. pseudomallei aos antibióticos, gerada pela exposição à drogas não antimicrobianas. Nesse panorama, o uso do farnesol como droga adjuvante mostrou-se promissor, uma vez que o composto desestruturou a matriz do biofilme, facilitando a penetração e, consequentemente, a ação dos antimicrobianos.
O presente trabalho também amplia o panorama para os estudos que buscam alternativas terapêuticas com a utilização do farnesol. No que se refere a sua administração in
vivo, foi demonstrado que a utilização do farnesol revelou efeito tóxico insignificante
(NAVARATHNA et al., 2007). Desse modo, pode-se presumir que a administração do composto em modelos murinos pode ser empregada para a realização de estudos in vivo que possam avaliar a ação do farnesol contra B. pseudomallei no organismo hospedeiro.
REFERÊNCIAS
ADLER L. N. R.; DEAN, R. E.; SAINT, R. J.; STEVENS, M. P.; PRIOR, J. L.; ATKINS, T. P.; GALYOV, E. E. Identification of a predicted trimeric autotransporter adhesin required for biofilm formation of Burkholderia pseudomallei. PloS one, v. 8, p. e79461, 2015.
ALLISON, D. G.; SUTHERLAND, I. W. “A staining technique for attached bacteria and its correlation to extracellular carbohydrate production.” Journal of Microbiological Methods, v. 2, p. 93–99, 1984.
ASHDOWN, L. R. “An improved screening for isolation of Pseudomonas pseudomallei from clinical specimens. Pathol., v. 11, p. 293-297, 1979.”
BANDEIRA, T. J. P. G.; MOREIRA, C. A.; BRILHANTE, R. S. N.; CASTELO-BRANCO, D. S. C. M.; NETO, M. P. A.; CORDEIRO, R. A.; RODRIGUES, T. J. S.; ROCHA, M. F. G.; SIDRIM, J. J. C. “In vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against biofilm of brazilian strains of
Burkholderia pseudomallei.” Antimicrobial agents and chemotherapy, v. 57, p. 5771–5773,
2013b.
BARTH, A. L.; SILVA, F. A. A.; HOFFMANN, A.; VIEIRA, M. I.; ZAVASCKI, A. P.; FERREIRA, A. G.; CUNHA, L. G. J.; ALBANO, R. M.; MARQUES, E. A. Cystic fibrosis patient with Burkholderia pseudomallei infection acquired in Brazil. Journal of Clinical
Microbiology, v. 45, p. 4077–4080, 2007.
BAYSTON, R.; PENNY, S. R. Excessive production of mucoid substance in Staphylococcus SIIA: a possible factor in colonisation of holter shunts. Developmental medicine and child
neurology. Supplement, v. 27, p. 25–28, 1972.
BEAMER, P. R.; VARNEY, P. L.; BROWN, W. G.; MCDOWELL, F.; ECK, B. Melioidosis: report of second case from the western hemisphere, with bacteriologic studies on both cases.
Archives of disease in childhood, v. 58, p. 717–718, 1983.
BIEGELEISEN, J. Z.; MOSQUERA, R. M.; CHERRY, W. B. A case of human melioidosis: clinical, epidemiological and laboratory findings. American Journal of Tropical Medicine and
Hygiene, v. 13, p. 89–99, 1964.
BIOT, F. V.; LOPEZ, M. M.; POYOT, T.; NEULAT-RIPOLL, F.; LIGNON, S.; CACLARD, A.; THIBAULT, F. M.; PEINNEQUIN, A.; PAGES, J. M. Interplay between three rnd efflux pumps in doxycycline-selected strains of Burkholderia thailandensis. PLoS ONE, v. 8, p. 1- 11, 2013.
BJARNSHOLT, T.; JENSEN, P. O.; BURMOLLE, M.; HENTZER, M.; HAAGENSEN, J. J.; HOUGEN, H. P.; CALUM, H.; MADSEN, K. G.; MOSER, C.; MOLIN, S.; HOIBY, N.
Pseudomonas aeruginosa Tolerance to Tobramycin, Hydrogen Peroxide and
Polymorphonuclear Leukocytes Is Quorum-Sensing Dependent. Microbiology, v. 151, p. 373–383, 2005.
BRENNER, D. J.; KRIEG, N. R.; STALEY, J. T. Bergey’s Manual of Systematic Bacteriology. The Proteobacteria, Part C, The Alpha-, Beta-, Delta-, and Epsilonproteobacteria. New York: Springer, 2nd ed., v. 2, p. 575-600, 2005.
BRILHANTE, R. S. N.; SILVA, N. F.; MARQUES, F. J.; CASTELO-BRANCO, D. S. C. M.; LIMA, R. A. C.; MALAQUIAS, A. D. M.; CAETANO, E. P.; BARBOSA, G. R.; CAMARGO, Z. P.; RODRIGUES, A. M.; MONTEIRO, J.; BANDEIRA, T. J. G. P.; SIDRIM, J. J. C.; CORDEIRO, R. A.; MOREIRA, L. B.; ROCHA, M. F. G. In vitro inhibitory activity of terpenic derivatives against clinical and environmental strains of the
Sporothrix schenkii complex. Medical Mycology, v. 00, p. 1–6, 2014.
BRILHANTE, R. S. N.; VALENTE, L. G. A.; ROCHA, M. F. G.; BANDEIRA, T. J. P. G.; CORDEIRO, R. A.; LIMA, R. A. C.; LEITE, J. J. G.; RIBEIRO, J. F.; PEREIRA, J. F.; CASTELO-BRANCO, D. S. C. M.; MONTEIRO, A. J.; SIDRIM, J. J. C. Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia
pseudomallei. Antimicrobial Agents and Chemotherapy, v. 56, p. 2198–2200, 2012.
BRILHANTE, R. S. N.; LIMA, R. A. C.; CAETANO, E. P.; LEITE, J. J. G.; CASTELO- BRANCO, D. S. C. M.; RIBEIRO, J. F.; BANDEIRA, T. J. P. G.; CORDEIRO, R. A.; MONTEIRO, A. J.; SIDRIM, J. J. C.; ROCHA, M. F. G. Effect of farnesol on growth, ergosterol biosynthesis, and cell permeability in Coccidioides posadasii. Antimicrobial Agents
and Chemotherapy, v. 57, p. 2167–2170, 2013.
CAMPOS, V. L.; ESCALANTE, G.; YAÑEZ, J.; ZAROR, C. A.; MONDACA, M. A. Isolation of arsenite-oxidizing bacteria from a natural biofilm associated to volcanic rocks of Atacama desert, Chile. Journal of Basic Microbiology, v. 49, p. 93–97, 2009.
CHAMBON, L. Isolement du bacille de whitmore a partir du milieu extérieur. Annales de
l’Institut Pasteur, v. 89, p. 229–235, 1955.
CHANCHAMROEN, S.; KEWCHAROENWONG, C.; SUSAENGRAT, W.; ATO, M.; LERTMEMONGKOLCHAI, G. Human polymorphonuclear neutrophil responses to
Burkholderia pseudomallei in healthy and diabetic subjects. Infection and Immunity, v. 77, p.
456–463, 2009.
CHEN, Y. S.; SHIEH, W. J.; GOLDSMITH, C. S.; METCALFE, M. G.; GREER, P. W.; ZAKI, S. R.; CHANG, H. H.; CHAN, H.; CHEN, Y. L. Alteration of the phenotypic and pathogenic patterns of Burkholderia pseudomallei that persist in a soil environment. American
Journal of Tropical Medicine and Hygiene, v.90, p. 469–479, 2014.
CHENG, A. C.; CURRIE, B. J. Melioidosis : epidemiology , pathophysiology and management. Clinical microbiology reviews, v. 18, p. 383–416, 2005.
CHENG, A. C.; MAYO, M. J.; GAL, D.; CURRIE, B. J. Chlorination and pH of drinking water do not correlate with rates of melioidosis in the Northern territory, Australia.
CHRISTENSEN, G. D., SIMPSON, W.;BISNO, L.; BEACHEY, E. H. Adherence of slime- producing strains of Staphylococcus epidermidis to smooth surfaces. Infection and Immunity, v. 37, p. 318–326, 1982.
CHUSRI, S.; HORTIWAKUL, T.; CHAROENMAK, B.; SILPAPOJAKUL, K. Outcomes of patients with melioidosis treated with cotrimoxazole alone for eradication therapy. American
Journal of Tropical Medicine and Hygiene, v. 87, p. 927–932, 2012.
CIEVS (2010) Boletim cievs. Estado de Alagoas.
CLSI. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved Guideline—Second Edition. CLSI document M45- A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
CLSI. Methods for dilution antimicrobial susceptibility tests f or bacteria that grow aerobically; Approved St andard—Ninth Edition. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute; 2012a.
CLSI. Performance standards for antimicrobial susceptibility testing; Twenty-Second Informational Supplement. CLSI document M100-S22. Wayne, PA: Clinical and Laboratory Standards Institute; 2012b.
CORDEIRO, R. A.; NOGUEIRA, G. C.; BRILHANTE, R. S. N.; TEIXEIRA, C. E. C.; MOURA, C. I.; CASTELO-BRANCO, D. S. C. M.; PAIVA, M. A. N.; RIBEIRO, J. F.; MONTEIRO, A. J.; SIDRIM, J. J. C.; ROCHA, M. F. G. Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence- related exoenzymes. Veterinary Microbiology, v. 159, p. 375–380, 2012.
CORDEIRO, R. A.; NOGUEIRA, G. C.; BRILHANTE, R. S. N.; TEIXEIRA, C. E. C.; MOURA, C. I.; CASTELO-BRANCO, D. S. C. M.; PAIVA, M. A. N.; LEITE, J. J. G.; LIMA, D. T.; MONTEIRO, A. J.; SIDRIM, J. J. C.; ROCHA, M. F. G. Minimum inhibitory concentrations of amphotericin b, azoles and caspofungin against Candida species are reduced by farnesol. Medical mycology, v. 51, p. 53–59, 2013.
CRAMTON, S. E.; GERKE, C.; GOTZ, F. In vitro methods to study Staphylococcal biofilm formation. Methos in enzymology, v. 336, p. 239–254, 2001.
CRUZ, A.; HAUTBERGUE1, G. M.; ARTYMIUK, P. J.; BAKER, P. J.; BOKORI-BROWN, M.; CHANG, C. T.; DICKMAN, M. J.; ESSEX-LOPRESTI, A.; HARDING, S. V.; MAHADI, N. M.; MARSHALL, L. E.; MOBBS, G. W.; MOHAMED, NATHAN, S.; NGUGI, S. A.; ONG, C.; OOI, W. F.; PARTRIDGE, L. J.; PHILLIPS, H. L.; RAIH, M. F.; RUZHENIKOV, S.; SARKAR-TYSON, M.; SEDELNIKOVA, S. E.; SMITHER, S. J.; TAN, P.; TITBALL, R. W.; WILSON, S. A.; RICE, D. W. A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A. Science, v. 334, p. 821–824, 2011.
CUADROS, J.; GIL, H.; DE MIGUEL, J.; MARABÉ, G.; ARROYO, T.; GÓMEZ-HERRUZ, P.; LOBO, B.; MARCOS, R.; ANDA, P. Case report: Melioidosis imported from West Africa to Europe. Am J Trop Med Hyg, v. 85, p. 282–284, 2011.
CURRIE, B. J.; FISHER, D. A.; ANSTEY, N. M.; JACUPS, S. P. Endemic melioidosis in tropical Northern Australia: a 10-year prospective study and review of the literature. Clinical
infectious diseases : an official publication of the Infectious Diseases Society of America, v.
31, p. 981–986, 2000.
CURRIE, B. J. Melioidosis : evolving concepts in epidemiology , pathogenesis , and treatment. Seminars in Respiratory and Critical Care Medicine, v. 36, p. 111–125, 2015. CURRIE, B. J.; WARD, L.; CHENG, A. C. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Neglected Tropical
Diseases, v. 4, p. e900, 2010.
DANCE, D. Treatment and prophylaxis of melioidosis. International Journal of
Antimicrobial Agents, v. 43, p.310–318, 2014.
DERENGOWSKI, L. S.; DE-SOUZA-SILVA, C.; BRAZ, S. V.; MELLO-DE-SOUSA, T. M.; BÁO, S. N.; KYAW, C. M.; SILVA-PEREIRA, I. Antimicrobial effect of farnesol, a
Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and
morphogenesis. Annals of Clinical Microbiology and Antimicrobials, v. 9, p. 1–9, 2009. DOJANI, S.; LAKATOSA, M.; RASCHERB, U.; WANEKC, W.; LÜTTGED, U.; BÜDEL, B. Nitrogen input by Cyanobacterial biofilms of an inselberg into a tropical rainforest in french guiana. Flora: Morphology, Distribution, Functional Ecology of Plants, v. 202, p. 521–529, 2007.
DRAPER, A. D. K.; MAYO, M.; HARRINGTON, G.; KARP, D.; YINFOO, D.; WARD, L.; HASLEM, A.; CURRIE, B. J.; KAESTLI, M. Association of the melioidosis agent
Burkholderia pseudomallei with water parameters in rural water supplies in Northern
Australia. Applied and Environmental Microbiology, v. 76, p. 5305–5307, 2010.
DUFOUR, D.; LEUNG, V.; LÉVESQUE, C. M.; Bacterial biofilm: structure, function, and antimicrobial resistance. Endodontic Topics, v. 22, p. 2–16, 2012.
ENGELTHALER, D. M.; BOWERS, J.; SCHUPP, J. A.; PEARSON, T.; GINTHER, J.; HORNSTRA, H. M.; DALE, J.; STEWART, T.; SUNENSHINE, R.; WADDELL, V.; LEVY, C.; GILLECE, J.; PRICE, L. B.; CONTENTE, T.; BECKSTROM-STERNBERG, S. M.; BLANEY, D. D.; WAGNER, D. M.; MAYO, M.; CURRIE, B. J.; KEIM, P.; TUANYOK, A. Molecular investigations of a locally acquired case of melioidosis in Southern AZ, USA. PLoS Neglected Tropical Diseases, v. 5, p. 3–8, 2011.
FLEMMING, H. C.; WINGENDER, J. The biofilm matrix. Nature reviews. Microbiology, v. 8, p. 623–633, 2010.
FOONG, Y. C.; TAN, M.; Bradbury, R. S. Melioidosis : A Review.” Rural and Remote
Health, v. 14, p. 1–16, 2014.
GAMAGE, A. M.; SHUI, G.; WENK, M. R.; CHUA, K. L. N-octanoylhomoserine lactone signalling mediated by the BpsI-BpsR quorum sensing system plays a major role in biofilm formation of Burkholderia pseudomallei. Microbiology, v. 157, p. 1176–1186, 2011.
GIRARD, G. Le porc peut-il être un porteur sain de bacille de Whitmore?. Bulletin de la
Société de pathologie exotique, v. 29, p. 712–716, 1936.
GOMES, F.; TEIXEIRA, P.; CERCA, N.; AZEREDO, J.; OLIVEIRA, R. Effect of farnesol on structure and composition of Staphylococcus epidermidis biofilm matrix. Current
Microbiology, v. 63, p. 354–359, 2011.
GRENIER. La Melioidose. Revue du corps de santé militaire, v. 9, p. 101–109, 1953.
HAMPTON, V.; KAESTLI, M.; MAYO, M.; CHOY, J. L.; HARRINGTON, G.; RICHARDSON, L.; BENEDICT, S.; NOSKE, R.; GARNETT, S. G. Melioidosis in birds and
Burkholderia pseudomallei dispersal, Australia. Emerging Infectious Diseases, v. 17, p. 405–
411, 2011.
HEISS, C.; BURTNICK, M. N.; WANG, Z.; AZADI, P.; BRETT, P. J. Structural analysis of capsular polysaccharides expressed by Burkholderia mallei and Burkholderia pseudomallei.
Carbohydrate Research, v. 349, p. 90–94, 2012.
HENRICI, A. T. A direct microscopic technique. Journal of bacteriology, p. 277–287, 1932. HEUKELEKIAN, H.; HELLER, A. Relation between food concentration and surface for bacterial growth. Journal of bacteriology, v. 40, p. 547–58, 1940.
HICKS, C. L.; KINOSHITA, R.; LADDS, W. Pathology of melioidosis in captive marine mammals. Australian Veterinary Journal, v. 78, p. 193–195, 2000.
HOIBY, N.; BJARNSHOLT, T.; GIVSKOV, M.; MOLIN, S.; CIOFU, O. Antibiotic resistance of bacterial biofilms. International Journal of Antimicrobial Agents, v. 35, p. 322– 332, 2010.
HOREV, B.; KLEIN, M. I.; HWANG, G.; LI, Y.; KIM, D.; KOO, H.; BENOIT, D. S. W. pH- activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. ACS Nano, p. 1-45, 2015.
HOUDT, R.; MICHIELS, C. W. Role of bacterial cell surface structures in Escherichia coli biofilm formation. Research in Microbiology, v. 156, p. 626–633, 2005.
HOWARD, K.; INGLIS, T. J. J. The effect of free chlorine on Burkholderia pseudomallei in potable water. Water Research, v. 37, p. 4425–4432, 2003.
HOWE, C.; SAMPATH, A.; SPOTNITZ, M. The pseudomallei group: a review. The Journal
of Infectious Diseases, v. 124, p. 598–606, 1971.
INGLIS, T. J. J. The treatment of melioidosis. Pharmaceuticals, v. 3, p. 1296–1303, 2010. INGLIS, T. J. J.; MEE, B. J.; CHANG, B. J. The environmental microbiology of melioidosis.
INGLIS, T. J. J.; ROLIM, D. B.; RODRIGUEZ, J. L. N. Clinical guideline for diagnosis and management of melioidosis. Revista do Instituto de Medicina Tropical de Sao Paulo, v. 48, p. 1–4, 2006.
JABRA-RIZK, M. A.; MEILLER, T. F.; JAMES, C. E.; SHIRTLIFF, M. E. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility.” Antimicrobial
Agents and Chemotherapy, v. 50, p. 1463–1469, 2006.
JIN, J.; ZHANG, J.; GUO, N.; SHENG, H.; LI, L.; LIANG, J. C.;WANG, X. L.; LI, Y.; LIU, M. Y.; WU, P.; YU, L. Farnesol, a Potential Efflux Pump Inhibitor in Mycobacterium
smegmatis. Molecules, v.15, p. 7750–7762, 2010.
JOHNSON, D. W. Melioidosis: report of four cases from torres strait. Medical Journal of
Australia, v. 2, p. 587–588, 1967.
JONES, D. S.; TOBLER, D. J.; SCHAPERDOTH, I.; MAINIERO, M.; MACALADY, J. L. Community structure of subsurface biofilms in the thermal sulfidic caves of acquasanta terme, Italy. Applied and Environmental Microbiology, v. 76, p. 5902–5910, 2010.
JOO, J. H.; JETTEN, A. M. Molecular mechanisms involved in farnesol-induced apoptosis.”
Cancer Letters, v. 287, p. 123–135, 2012.
KAMJUMPHOL, W.; CHAREONSUDJAI, S.; CHAREONSUDJAI, P.;
WONGRATANACHEEWIN, S.; TAWEECHAISUPAPONG, S. Environmental factors affecting. Southeast Asian J Trop Med Public Health, v. 44, p. 72–81, 2013.
KATRAGKOU, A.; MCCARTHY, M.; ALEXANDER, E. L.; ANTACHOPOULOS, C.; MELETIADIS, J.; JABRA-RIZK, M. A.; PETRAITIS, V.; ROILIDES, E.; WALSH, T. J. In
vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. J Antimicrob Chemother, v. 70, p. 470–478, 2014.
KINGSTON, C. W. Chronic or latent melioidosis. Medical Journal of Australia, v. 2, p. 618– 621, 1971.
KOH, S. F.; TAY, S. T.; PUTHUCHEARY, S. D. Colonial morphotypes and biofilm forming ability of Burkholderia pseudomallei. Tropical Biomedicine, v. 30, p. 428–433, 2013.
KONEMAN, E.; WASHINGTON, W. J.; ALLEN, S.; JANDA, W.; PROCOP, G.; SCHRECKENBERGER, P.; WOODS, G. Diagnóstico Microbiológico: Texto E Atlas
Colorido. edited by São Paulo: Guanabara. 2008, p. 1565.
KRÓL, J. E.; NGUYEN, H. D.; ROGERS, L. M.; BEYENAL, H.; KRONE, S. M. Increased transfer of a multidrug resistance plasmid in Escherichia coli biofilms at the air-liquid interface. Applied and Environmental Microbiology, v. 77, p. 5079–5088, 2011.
KURODA, M.; NAGASAKI, S.; OHTA, T. Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to b -lactams in methicillin-resistant Staphylococcus aureus.” Journal of Antimicrobial
LEE, J. H.; KIM, C.; KIM, S. H.; SETHI, G.; AHN, K. S. Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway. Cancer Lett, v. 360, p. 280–293, 2015. LIMMATHUROTSAKUL, D.; PAEYAO, A.; WONGRATANACHEEWIN, S.; SAIPROM, N.; TAKPHO, N.; THAIPADUNGPANIT, J.; CHANTRATITA, N.; WUTHIEKANUN, V.; DAY, N. P. J.; PEACOCK, S. J.; KAEN, K. Role of Burkholderia pseudomallei biofilm formation and lipopolysaccharide in relapse of melioidosis introduction. Clinical
Microbiology and Infection, v. p. 10–12, 2014.
LIMMATHUROTSAKUL, D.; CHAOWAGUL, W.; CHIERAKUL, W.; STEPNIEWSKA, K.; MAHARJAN, B.; WUTHIEKANUN, V.; WHITE, N. J.; DAY, N. P. J.; PEACOCK, S. J. Risk factors for recurrent melioidosis in Northeast Thailand. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, v. 43, p. 979–986, 2006.
LIMMATHUROTSAKUL, D.; THAMMASART, S.; WARRASUTH, N.;
THAPANAGULSAK, P.; JATAPAI, A.; PENGREUNGROJANACHAI, V.; ANUN, S.; JORAKA, W.; THONGKAMKOON, P.; SAIYEN, P.; WONGRATANACHEEWIN, S.; DAY, N. P. J.; PEACOCK, S. J. Melioidosis in animals, Thailand, 2006-2010. Emerging
Infectious Diseases, v. 18, p. 325–327, 2012.
LIMMATHUROTSAKUL, D.; PEACOCK, S. J. Melioidosis: A Clinical Overview. British
Medical Bulletin, v. 99, p. 125–139, 2011.
LOWE, W.; MARCH, J. K.; BUNNELL, A. J.; O’NEILL, K. L.; ROBISON, R. A. PCR- based methodologies used to detect and differentiate the Burkholderia pseudomallei complex:
B. pseudomallei, B. mallei, and B. thailandensis. Curr Issues Mol Biol, v. 16, p. 23–54, 2014.
MACEDO, R. N.; ROCHA, F. A.; ROLIM, D. B.; VILAR, D. C. L. F.; ARAÚJO, F. M. C.; VIEIRA, N. N.; TEIXEIRA, J. R.; CARVALHO, M. C.; OLIVEIRA, F. G. M.; CAVALCANTI, L. P. G. Severe coinfection of melioidosis and dengue fever in Northeastern Brazil: first case report. Revista da Sociedade Brasileira de Medicina Tropical, v. 45, p. 132– 133, 2012.
MAHARJAN, B.; CHANTRATITA, N.; VESARATCHAVEST, M.; CHENG, A.; WUTHIEKANUN, V.; CHIERAKUL, W.; CHAOWAGUL, W.; DAY, N. P. J.; PEACOCK, S. J. Recurrent melioidosis in patients in Northeast Thailand is frequently due to reinfection rather than relapse. Journal of Clinical Microbiology, v. 43, p. 6032–6034, 2005.
MARCHESE, A.; BOZZOLASCO, M.; GUALCO, L.; DEBBIA, E. A.; SCHITO, G. C.; SCHITO, A. M. Effect of fosfomycin alone and in combination with n-acetylcysteine on E.
coli biofilms. International Journal of Antimicrobial Agents, v. 22, p. 95–100, 2003.
MARSHALL, K. C.; STOUT, R.; MITCHELL, R. Mechanism of the initial events in the sorption of marine bacteria to surfaces. Journal of General Microbiology, v. 68, p. 337–348, 1971.
MATARACI, E.; DOSLER, S. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms. Antimicrobial Agents Chemotherapy, v. 56, p. 6366–6371, 2012.
MERIANOS, A.; PATEL, M.; LANE, J. M.; NOONAN, C. N.; SHARROCK, D.; MOCK, P. A.; CURRIE, B. J. The 1990-1991 outbreak of melioidosis in the northern territory of australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public
Health, v. 24, p. 425–435, 1993.
MOLLARET, H. H. L’affaire du jardin des plantes’ ou comment la mdliordose fit son apparition en france. Médecine et Maladies Infectieuses, v. 18, p. 643–654, 1988.
NANDI, T.; ONG, C.; SINGH, A. P.; BODDEY, J.; ATKINS, T.; SARKAR-TYSON, M.; ESSEX-LOPRESTI, A.; CHUA, H.; PEARSON, T.; KREISBERG, J. F.; NILSSON, C.; ARIYARATNE, P.; RONNING, C.; LOSADA, L.; RUAN, Y.; SUNG, W. K.; WOODS, D.; TITBALL, R. W.; BEACHAM, I.; PEAK, I.; KEIM, P.; NIERMAN, W. C.; TAN, P. A. Genomic survey of positive selection in Burkholderia pseudomallei provides insights into the evolution of accidental virulence. PLoS pathogens, v. 6, p. e1000845, 2010.
NAVARATHNA, D. H.; HORNBY, J. M.; KRISHNAN, N.; PARKHURST, A.; DUHAMEL, G. E.; NICKERSON, K. W. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect Immun. v. 75, p. 1609-1618, 2007.
NGAUY, V.; YAN, L.; LEE, S.; CRAWFORD, G. Cutaneous melioidosis in a man who was taken as a prisoner of war by the japanese during world war II. Journal of Clinical
Microbiology, v. 43, p. 970–972, 2005.
NOVAK, R. T.; GLASS, M. B.; GEE, J. E.; GAL, D.; MAYO, M. J.; CURRIE, B. J.; WILKINS, P. P. Development and evaluation of a real-time pcr assay targeting the type III secretion system of Burkholderia pseudomallei. Journal of Clinical Microbiology, v. 44, p. 85–90, 2006.
OKAJIMA, Y.; SHINICHIRO, K.; AKIYOSHI, T.; TOCHIKUBO, T. Biofilm formation by
Staphylococcus epidermidis on intraocular lens material. Investigative Ophthalmology and Visual Science, v. 47, p. 2971–2975, 2006.
PANOMKET, P.; SURASAK, W.; THANYAKARN, S.; NIPAWAN, P. Bioactivity of plant extracts against Burkholderia pseudomallei. Asian Biomedicine, v. 6, p. 619–623, 2012. PARAMESWARAN, U.; ROBERT W.; BAIRD, L.; WARD, M.; CURRIE, B. J. Melioidosis at Royal Darwin Hospital in the big 2009-2010 wet season: comparison with the preceding 20 years. Medical Journal of Australia, v. 196, p. 345–348, 2012.
PEACOCK, S. J.; CHIENG, G.; CHENG, A. C.; DAVID, A.; DANCE, B.; AMORNCHAI, P.; WONGSUVAN, G.; CHIERAKUL, W.; NICHOLAS, P. J.; DANCE, D. B.; TEERAWATTANASOOK, N.; Day, N. P. J. Comparison of Ashdown’s medium,
isolation of Burkholderia pseudomallei. Journal of Clinical Microbiology, v. 43, p. 5359– 5361, 2005.
PEETERS, E.; NELIS, H. J.; COENYE, T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. Journal of Microbiological
Methods, v. 72, p. 157–165, 2008.
PERCIVAL, S. L.; ALICE J. G.; COCHRANE, C. A. Introduction to biofilms. Biofilms and
Veterinary Medicine, v. 6, p. 111–128, 2011.
PODIN, Y.; KAESTLI, M.; MCMAHON, N.; ENNESSY, J.; NGIAN, H. U.; WONG, J. S.; MOHANA, A.; WONG, S. C.; WILLIAM, T.; AYO, M.; BAIRD, R. W.; CURRIE, B. J. Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent. Journal of Clinical Microbiology, v. 51, p. 3076–3078, 2013.
PUMIRAT, P.; BROEK, C. V.; JUNTAWIENG, N.; MUANGSOMBUT, V.; KIRATISIN, P.; PATTANAPANYASAT, K.; STEVENS, J. M.; STEVENS, M. P.; KORBSRISATE, S. Analysis of the prevalence, secretion and function of a cell cycle-inhibiting factor in the melioidosis pathogen Burkholderia pseudomallei. PLoS ONE, v. 9, p. e96298, 2014.
QAMAR, W.; KHAN, A. Q.; KHAN, R.; LATEEF, A.; TAHIR, M.; REHMAN, M. U.; ALI, F.; SULTANA, S. Benzo(a)pyrene-induced pulmonary inflammation, edema, surfactant dysfunction, and injuries in rats: alleviation by farnesol. Experimental Lung Research, v. 38, p. 19–27, 2012.
RAETZ, C. R. H.; REYNOLDS, C. M.; TRENT, M. S.; BISHOP, R. E. Lipid A odification systems in Gram-negative bacteria. Annu Rev Biochem, v. 76, p. 295–329, 2007.
RECKSEIDLER-ZENTENO, S. L.; DEVINNEY, R.; WOODS, D. E. The Capsular Polysaccharide of. Infection and Immunity, v. 73, p. 1106–1115, 2005.
REX, J. H.; PFALLER, M. A. Has antifungal susceptibility testing come of age? Clinical
infectious diseases : an official publication of the Infectious Diseases Society of America, v.
35, p. 982–989, 2002.
RIMINGTON, R. A. Melioidosis in North Queensland. Medical Journal of Australia, v. 1, p. 50–53, 1962.
ROLIM, D. B.; ROCHA, M. F. G.; BRILHANTE, R. S. N.; CORDEIRO, R. A.; LEITÃO, N. P.; INGLIS, T. J. J.; SIDRIM, J. J. C. Environmental isolates of Burkholderia pseudomallei in Ceará state, Northeastern Brazil. Applied and Environmental Microbiology, v. 75, p. 1215– 1218, 2009.
ROLIM, D. B.; VILAR, D. C. F. L.; CAVALCANTI, L. G. P.; FREITAS, L. B. N.; INGLIS, T. J. J.; RODRIGUES, J. L. N.; NAGAO-DIAS, A. T. Burkholderia pseudomallei antibodies in individuals living in endemic regions in Northeastern Brazil. American Journal of Tropical
ROVETA, S.; SCHITO, A. M.; MARCHESE, A.; SCHITO, G. C. Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis. International Journal of Antimicrobial Agents, v. 30, p. 415–421, 2007. RUBIN, H. L.; ALEXANDER, A. D.; YAGER, R. H. Melioidosis a military medical problem? Military medicine, v. 128, p. 538–542, 1963.
SAINI, H.; CHHIBBER, S.; HARJAI, K. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections. International Journal of Antimicrobial Agents, v.p. 1–9, 2014.
SANFORD, J. P.; MANDELL, G.; DOUGLAS, J.; BENNETT, J. E. Pseudomonas Species
(including Melioidosis and Glanders), in Principles and Pratice of Infectious Diseases, 3rd Ed., 1990.
SAWASDIDOLN, C.; TAWEECHAISUPAPONG, S.; SERMSWAN, R. W.;
TATTAWASART, U.; TUNGPRADABKUL, S.; WONGRATANACHEEWIN, S. Growing
Burkholderia pseudomallei in biofilm stimulating conditions significantly induces
antimicrobial resistance. PLoS One, v. 5, p. 1–10, 2010.
SCHWEIZER, H. P. Mechanisms of Antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis. Future Microbiology, v. 7, p. 1389–1399, 2012. SEMIGHINI, C. P.; MURRAY, N.; HARRIS, S. D. Inhibition of Fusarium graminearum growth and development by farnesol. FEMS Microbiology Letters, v. 279, p. 259–264, 2008. SESA (2008) Informe Ambiental MELIOIDOSE no 3.
SIDRIM J; ROCHA M (2004) Micologia médica à luz de autores contemporâneos. Guanabara, ed. Rio de Janeiro.
SIDRIM, J. J. C.; ROCHA, M. F. G.; BANDEIRA, T. J. P. G.; CORDEIRO, R. A.; CARVALHO, B. M.; GRANGEIRO, T. B.; HOLANDA, M. A.; LIMA, R. A. C.; VALENTE, L. G. A.; COSTA, A. K. F.; BRILHANTE, R. S. N. Mycotic aneurysm caused by Burkholderia pseudomallei : report of a brazilian strain genetically related to thai strains.
Clinical Microbiology and Infection v. 17, p. 2010–2012, 2011.
SIRITAPETAWEE, J.; PRINZ, H.; SAMOSORNSUK, W.; ASHLEY, R. H.; SUGINTA, W. Functional reconstitution, gene isolation and topology modelling of porins from Burkholderia
pseudomallei and Burkholderia thailandensis. The Biochemical journal, v. 377, p. 579–587,
2004.
SMITH, M. D.; ANGUS, B. J.; WUTHIEKANUN, V.; WHITE, N. J. Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Infection and Immunity, v. 65, p. 4319–4321, 1997.
SPRAGUE, L. D.; NEUBAUER, H. Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation. Journal of Veterinary Medicine Series B: Infectious
STANTON, A. T.; FLETCHER, W. Melioidosis: a new disease of the tropics. Fourth
Congress of the Far Eastern Association of Tropical Medicine, v. 2, p. 196–198, 1921.
STEWART, T.; ENGELTHALER, D. M.; BLANEY, D. D.; TUANYOK, A.; WANGSNESS, E.; SMITH, T. L.; PEARSON, T.; KOMATSU, K. K.; KEIM, P.; CURRIE, B. J.; LEVY, C.; SUNENSHINE, R. Melioidosis in 6 Tsunami survivors in Southern Thailand. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, v. 41, p. 982–990, 2005.
STONE, J. K.; DESHAZER, D.; BRETT, P. J.; BURTNICK, M. N. Melioidosis: molecular aspects of pathogenesis. Expert Review of Anti-infective Therapy, v. 12(12):1487–1499, 2014. TEIXEIRA, CEC. 2011. Efeito Do Farnesol Sobre O Fenótipo de Resistência E a Produção de Fosfolipase E Protease Em Cepas de Candida spp. Dissertação. Programa de Pós- Graduação Em Microbiologia Médica - PPGMM, Universidade Federal Do Ceará - UFC, 2011.” Universidade Federal do Ceará - UFC.
THOMAS, A. D.; FORBES-FAULKNER, J. C. Persistence of Pseudomonas pseudomallei in soil.” Australian Veterinary Journal, v. 57, p. 535–536, 1981.
TRAN, P. L.; HAMMOND, A. A.; MOSLEY, T.; CORTEZ, J.; GRAY, T.; COLMER- HAMOOD, J. A.; SHASHTRI, M.; SPALLHOLZ, J. E.; HAMOOD, A. N.; REID, T. W. Organoselenium coating on cellulose inhibits the formation of biofilms by Pseudomonas
aeruginosa and Staphylococcus aureus. Applied and Environmental Microbiology, v. 75, p.
3586–3592, 2009.
VORACHIT, M.; LAM, K.; JAYANETRA, P.; COSTERTON, J. W. Electron microscopy study of the mode of growth of Pseudomonas pseudomallei in vitro and in vivo. The American
journal of tropical medicine and hygiene, v. 98, p. 379–391, 1995.
WALL, R. A.; MABEY, D. C. W.; CORRAH, P. T.; PETERS, L. A Case of melioidosis in West Africa. The Journal of Infectious Diseases, v. 152, p. 424–425, 1985.
WANG, C.; YOON, S. H.; SHAH, A. A.; CHUNG, Y. R.; KIM, J. Y.; CHOI, E. S.; KEASLING, J. D.; KIM, S. W. Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway. Biotechnol Bioeng, v. 107, p. 421–429, 2010.
WANG-NGARM, S.; CHAREONSUDJAI, S.; CHAREONSUDJAI, P. Physicochemical factors affecting the growth of Burkholderia pseudomallei in soil microcosm. The American
journal of tropical medicine and hygiene, v. 90, p. 480–485, 2014.
WATERS, V.; RATJEN, F.; Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Cochrane database of systematic reviews, p. 1–20, 2012.
WATNICK, P.; KOLTER, R. Biofilm, city of microbes. Journal of Bacteriology, v. 182, p. 2675–2679, 2000.
WHITE, N. J.; DANCE, D. A.; CHAOWAGUL, W.; WATTANAGOON, Y.; WUTHIEKANUN, V.; PITAKWATCHARA, N. Halving of mortality of severe melioidosis by ceftazidime. Lancet, v. 2, p. 697–701, 1989.
WHITMORE, A.; KRISHNASWAMI, C. S. An account of the discovery of a hitherto undescribed infective disease occurring among the population of Rangoon. Indian Medical
Gazette, v. 47, p. 262–267, 1912.
WHITMORE, A. M. D. An account of a glanders-like disease occurring in Rangoon. The
Journal of hygiene, v. 13, p. 1–34, 1913.
WOLCOTT, R. D.; EHRLICH, G. D. Biofilms and Chronic Infections. JAMA : the journal of the American Medical Association, v. 299, p. 2682–2684, 2008.
YABUUCHI, E.; KOSAKO, Y.; OYAIZU, Y.; YANO, I.; HOTTA, H.; HASHIMOTO, H.; EZAKI, Y.; ARAKAWA, M. To the new genus , with the type species Burkholderia.
Microbiology Immunology, v. 40, p. 1251–1275, 1992.
YANG, S. J.; OH, H. M.; CHUNG, S.; CHO, J. C. Antarcticimonas flava gen. nov., sp. nov., isolated from Antarctic Coastal Seawater. Journal of Microbiology, v. 47, p. 517–523, 2009. YU, H. G.; CHUNG, H.; YOUNG, S.; SEO, J. M.; HEO, J. W. A new rapid and non- radioactive assay for monitoring and determining the proliferation of retinal pigment epithelial cells. Korean Journal of Ophthalmology, v. 17, p. 29–34, 2003.
ZOBELL, C. E. The effect of solid surfaces upon bacterial activity. Journal of Bacteriology, v. 46, p. 39–59, 1943.